Paragon Biosciences

Biotechnology, Health Care, Life Science, Pharmaceutical
Founded in 1/1/10
Chicago, Illinois, United States
http://www.paragonbiosci.com
For Profit

About Paragon Biosciences

Paragon Biosciences is a global healthcare company committed to accelerating biomedical research. It solves complex challenges by advancing science. Paragon focuses on four areas of life science innovation including artificial intelligence, gene therapy, synthetic biology, and biopharmaceuticals. Its current portfolio includes Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies in development. Paragon stands at the intersection of human need, life science, and company creation. The company was founded in 2010 and is headquartered in Northbrook, Illinois.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: 2018
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $10M to $50M
  • Total Funding: 282633366 USD
  • Last Funding: 185000000 USD (Undisclosed)
  • Funding Status: M&A

Technology Stack

Paragon Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Life Science, Pharmaceutical

Headquarters: Chicago, Illinois, United States

Employees

  • Darien Parhad - Chief Financial Officer (LinkedIn)
  • Spiro Katerinis - Chief Technology Officer (LinkedIn)